ICRA reaffirms ‘BBB-’ rating to Astec Lifesciences’ various bank facilities

06 May 2013 Evaluate

Credit rating agency, ICRA has reaffirmed the ‘BBB-’ rating assigned to Rs 16 crore, long-term loans, $3.91 million ECB loan and the Rs 34.0 crore long-term, fund-based bank facilities of Astec Lifesciences. The outlook on the long-term rating is stable. The rating agency has also reaffirmed the A3 rating assigned to the Rs 20.0 crore, short term, non-fund based bank facilities of Astec.

The reaffirmation of the ratings favourably factor in the expertise of the promoters with over three decades of experience in the agrochemicals industry and the company’s established market position in the manufacture and sale of triazole fungicides.

Astec LifeSciences is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates.

Astec Lifesciences Share Price

1060.65 8.50 (0.81%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
UPL 566.10
BASF India 5635.90
PI Industries 4115.15
Bayer CropScience 5726.95
Sumitomo Chemical India 513.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.